3 results
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
4 Dec 23
Report of Foreign Private Issuer
4:00pm
International, New York (US) - Med’Startup, 2019
Mercure Entrepreneurs Award - HEC Paris 2019
Women Trajectory’s Award - HEC Paris 2018
Elected
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
30 Aug 23
Report of Foreign Private Issuer
5:25pm
patients making it possible for Mazindol ER to be a potential class-leading treatment for narcolepsy in the future. I must also thank the many women
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
22 Dec 22
NLS Pharmaceutics CEO Issues Letter to Shareholders
9:40am
in the future. I must also thank the many women and men across Europe and the U.S. that are part of the NLS Pharmaceutics team, from pre-clinical
- Prev
- 1
- Next